EMEA-001142-PIP01-11-M02

Key facts

Invented name
Zerbaxa
Active substance
  • Ceftolozane
  • tazobactam
Therapeutic area
Infectious diseases
Decision number
P/0088/2017
PIP number
EMEA-001142-PIP01-11-M02
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
  • Treatment of abdominal and gastrointestinal infections
  • Treatment of urinary tract infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Ltd
France
E-mail: pip.information@merck.com
Tel. +33 (0)180464738
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating